Pfizer has outperformed the S&P 500 since my previous call, driven by improving fundamentals and renewed share price momentum ...

Pfizer PFE is set to release its fourth-quarter and full-year 2025 results on Feb. 3, with investor attention focused on ...

Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...

We recently published 10 Stocks Jim Cramer Talked About. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked ...

Albert Bourla said Pfizer has discussed a fast-pass voucher with the White House during the JPMorgan Healthcare Conference.

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...

国家药品监督管理局药品审评中心数据显示，2026年1月6日，Pfizer Europe MA EEIG的氯苯唑酸软胶囊申请已获受理，受理号为JYHB2600018。 声明 ：市场有风险，投资需谨慎。

Pfizer is gearing up for a consumer-driven obesity drug market, drawing parallels to the demand surge it experienced with the ...

However, there's one potentially lucrative growth opportunity that Pfizer's focusing on that could change things and ...

Ford's trailing-12-month dividend yield is around 4.5%, while Pfizer's is around 6.9%.

Dividend-paying stocks can really boost an individual investor's portfolio. If you're in the market for some no-brainer ...